The global rheumatoid arthritis therapeutics market was valued at USD 29,506.4 Million in 2024 and is projected to grow at a CAGR of 4.60% from 2025 to 2034. Driven by the rising prevalence of the disease, the market is expected to reach USD 44,228.4 Million by 2034, with significant growth anticipated in treatment innovation and accessibility. https://www.expertmarketresearch.com/reports/rheumatoid-arthritis-therapeutics-market